Chemoinformaics analysis of 6-HEPTADECENYLSALICYLIC-ACID
Molecular Weight | 205.169 | nRot | 1 |
Heavy Atom Molecular Weight | 198.113 | nRig | 13 |
Exact Molecular Weight | 205.038 | nRing | 2 |
Solubility: LogS | -2.857 | nHRing | 1 |
Solubility: LogP | 0.812 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 22 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 7 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 1 | No. of Arom Atom | 10 |
No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
nHA | 3 | APOL | 25.6756 |
nHD | 3 | BPOL | 9.32845 |
QED | 0.646 |
Synth | 2.2 |
Natural Product Likeliness | 0.492 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.003 |
HIA | 0.065 |
CACO-2 | -5.266 |
MDCK | 0.00000438 |
BBB | 0.208 |
PPB | 0.428819 |
VDSS | 0.56 |
FU | 0.509705 |
CYP1A2-inh | 0.111 |
CYP1A2-sub | 0.103 |
CYP2c19-inh | 0.051 |
CYP2c19-sub | 0.045 |
CYP2c9-inh | 0.019 |
CYP2c9-sub | 0.272 |
CYP2d6-inh | 0.008 |
CYP2d6-sub | 0.137 |
CYP3a4-inh | 0.034 |
CYP3a4-sub | 0.039 |
CL | 3.34 |
T12 | 0.913 |
hERG | 0.02 |
Ames | 0.012 |
ROA | 0.283 |
SkinSen | 0.28 |
Carcinogencity | 0.03 |
EI | 0.922 |
Respiratory | 0.963 |
NR-Aromatase | 0.007 |
Antiviral | No |
Prediction | 0.801435 |